Molbio Diagnostics Limited IPO
Medical Equipment & Supplies · DRHP 23 Aug 2025 · RHP 3 Aug 2026 · listed 17 Aug 2026
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹807.00
- band ₹768.00 to ₹807.00
- Fresh issue
- ₹200.0 cr
- plus any offer for sale
- Lot
- 18 shares
- ₹14,526 at the top of the band
- Subscription window
- 10 Aug to 12 Aug
- 2026
- Listing
- 17 Aug 2026
- NSE
- Subscribed
- 43.1x
- retail 9.1x
About the Molbio Diagnostics IPO
Molbio Diagnostics Limited raised money through a mainboard IPO on NSE and BSE: a fresh issue of ₹200 crore.
Bidding ran Mon 10 Aug to Wed 12 Aug, at an issue price of ₹807 a share, in lots of 18 shares. The shares listed on 17 Aug 2026.
The book-running lead managers are Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited and Jefferies India Private Limited. The registrar, which handles allotment, is KFin Technologies Limited.
The issue was subscribed 43.07 times overall, with the retail portion at 9.08 times, as the exchange's bid book showed.
The draft offer document was filed on 23 Aug 2025, and the red herring prospectus on 3 Aug 2026.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Molbio Diagnostics IPO: questions answered
When was the Molbio Diagnostics IPO open, and what were the price band and lot size?
Bidding ran Mon 10 Aug to Wed 12 Aug. The issue price is ₹807 a share. One lot is 18 shares, ₹14,526 at the upper end of the band.
When did the Molbio Diagnostics IPO list?
The shares listed on 17 Aug 2026 on NSE and BSE.
How do I check the Molbio Diagnostics IPO allotment status?
Allotment is finalised by the registrar, KFin Technologies Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Molbio Diagnostics IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Molbio Diagnostics IPO?
The book-running lead managers are Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited and Jefferies India Private Limited. The registrar, which handles applications and allotment, is KFin Technologies Limited.
How many times was the Molbio Diagnostics IPO subscribed?
43.07 times overall, as the exchange's bid book last showed: qualified institutions 108.63 times, non-institutional investors 33.01 times and retail 9.08 times.
Is the Molbio Diagnostics IPO a fresh issue or an offer for sale?
A fresh issue of ₹200 crore, which goes to the company.
What is the Molbio Diagnostics IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Molbio Diagnostics IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.